prednisone has been researched along with Spinal Fractures in 36 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Spinal Fractures: Broken bones in the vertebral column.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare bone mass loss due to deflazacort versus prednisone in longterm treatment of patients with giant cell arteritis (GCA) in a randomized double blind comparative trial." | 9.09 | Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. ( Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM, 2001) |
| "Osteoporosis is a common complication of long-term glucocorticoid therapy for which there is no well-proved preventive or restorative treatment." | 6.69 | Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. ( Brown, JP; Czachur, M; Daifotis, AG; Delmas, PD; Emkey, R; Goemaere, S; Hawkins, F; Liberman, UA; Malice, MP; Saag, KG; Schnitzer, TJ; Thamsborg, G, 1998) |
| "Osteoporosis is a recognized complication of corticosteroid therapy." | 6.68 | Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. ( Adachi, JD; Bensen, WG; Brown, J; Chines, AA; Hanley, D; Hodsman, A; Josse, R; Kendler, DL; Lentle, B; Olszynski, W; Ste-Marie, LG; Tenenhouse, A, 1997) |
| "To compare bone mass loss due to deflazacort versus prednisone in longterm treatment of patients with giant cell arteritis (GCA) in a randomized double blind comparative trial." | 5.09 | Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. ( Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM, 2001) |
| " Group 1 (67 patients) had steroid dependent asthma (mean daily dose of prednisone 11." | 3.68 | Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. ( Del Rio, L; Guañabens, N; Luengo, M; Montserrat, JM; Picado, C; Setoain, J, 1991) |
| "Osteoporosis is a common complication of long-term glucocorticoid therapy for which there is no well-proved preventive or restorative treatment." | 2.69 | Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. ( Brown, JP; Czachur, M; Daifotis, AG; Delmas, PD; Emkey, R; Goemaere, S; Hawkins, F; Liberman, UA; Malice, MP; Saag, KG; Schnitzer, TJ; Thamsborg, G, 1998) |
| "Osteoporosis is a recognized complication of corticosteroid therapy." | 2.68 | Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. ( Adachi, JD; Bensen, WG; Brown, J; Chines, AA; Hanley, D; Hodsman, A; Josse, R; Kendler, DL; Lentle, B; Olszynski, W; Ste-Marie, LG; Tenenhouse, A, 1997) |
| "LDAS was described as Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score ≤4, prednisone ≤7." | 1.91 | Low disease activity state associated with fewer incident vertebral fractures in Mestizo women with systemic lupus erythematosus. ( Ayón-Aguilar, J; Etchegaray-Morales, I; García-Carrasco, M; Méndez-Martínez, S; Mendoza-Pinto, C; Munguía-Realpozo, P; Osorio-Peña, ÁD; Ramírez-Lara, E; Solis-Poblano, JC; Zárate-Arellano, D, 2023) |
| " The dosage of glucocorticoids was higher among women than men (11." | 1.36 | Glucocorticoid-related osteoporotic fractures. ( Al-Elq, AH; Al-Omran, AS; Al-Osail, AM; Azzam, Q; Sadat-Ali, M, 2010) |
| "Zoledronic acid is a new intravenous bisphosphonate that has been approved by the US FDA for use with hypercalcemia of malignancies and might be an effective treatment for postmenopausal osteoporosis." | 1.32 | The effect of intravenous zoledronic acid on glucocorticoid-induced multiple vertebral fractures in juvenile systemic lupus erythematosus. ( Borges, CT; Jorgetti, V; Pereira, RM; Souza, SC, 2004) |
| "Osteoporosis is a major complication of long-term corticosteroid administration, but the magnitude of the effect in patients with chronic obstructive pulmonary disease (COPD) is not well defined." | 1.30 | Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. ( Bender, E; Ensrud, KE; Genant, HK; Griffith, JM; McEvoy, CE; Niewoehner, DE; Yu, W, 1998) |
| "Sacral insufficiency fractures developed in 4 of 386 patients." | 1.29 | Sacral insufficiency fractures in rheumatoid arthritis. ( Baker, MR; Place, HM; Troutner, JL; West, SG, 1994) |
| " Vertebral fractures (VF) were found in four men and were associated with higher prednisone dosage (P < 0." | 1.29 | Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. ( Bonnardeaux, A; Cardinal, J; Gagné, M; Ouimet, D; Pichette, V; Prudhomme, L, 1996) |
| "Therapies to prevent bone loss and treat established osteoporosis are uncommonly utilized in glucocorticoid-treated patients with end-stage pulmonary disease." | 1.29 | Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. ( Addesso, V; Donovan, D; Jorgesen, B; McGregor, C; Papadopoulos, A; Schulman, L; Shane, E; Silverberg, SJ; Staron, RB, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 15 (41.67) | 18.2507 |
| 2000's | 11 (30.56) | 29.6817 |
| 2010's | 5 (13.89) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chieng, H | 1 |
| Hafner, JP | 1 |
| Mccarthy, L | 1 |
| Ibrahim, A | 1 |
| Itty, R | 1 |
| Chong, WH | 1 |
| Saha, B | 1 |
| Conuel, E | 1 |
| Mendoza-Pinto, C | 1 |
| Etchegaray-Morales, I | 1 |
| Munguía-Realpozo, P | 1 |
| Osorio-Peña, ÁD | 1 |
| Méndez-Martínez, S | 1 |
| Ramírez-Lara, E | 1 |
| Zárate-Arellano, D | 1 |
| Solis-Poblano, JC | 1 |
| Ayón-Aguilar, J | 1 |
| García-Carrasco, M | 1 |
| Sun, S | 1 |
| Xu, B | 1 |
| Zhang, Q | 1 |
| Zhao, CS | 1 |
| Ma, R | 1 |
| He, J | 1 |
| Zhang, Y | 1 |
| Malochet-Guinamand, S | 1 |
| Lambert, C | 1 |
| Gossec, L | 1 |
| Soubrier, M | 1 |
| Dougados, M | 1 |
| Zhang, XD | 1 |
| Madjidyar, J | 1 |
| Peters, S | 1 |
| Velázquez Benito, A | 1 |
| Bellosta Diago, E | 1 |
| Santos Lasaosa, S | 1 |
| Pascual Millán, LF | 1 |
| Masala, S | 1 |
| Anselmetti, GC | 1 |
| Marcia, S | 1 |
| Massari, F | 1 |
| Manca, A | 1 |
| Simonetti, G | 1 |
| Regio, P | 1 |
| Bonfá, E | 1 |
| Takayama, L | 1 |
| Pereira, R | 1 |
| Husein-Elahmed, H | 1 |
| Aneiros-Fernandez, J | 1 |
| Arias-Santiago, S | 1 |
| Aneiros-Cachaza, J | 1 |
| Naranjo-Sintes, R | 1 |
| Sbrocchi, AM | 1 |
| Rauch, F | 1 |
| Matzinger, M | 1 |
| Feber, J | 1 |
| Ward, LM | 1 |
| Al-Osail, AM | 1 |
| Sadat-Ali, M | 1 |
| Al-Elq, AH | 1 |
| Al-Omran, AS | 1 |
| Azzam, Q | 1 |
| Yen, D | 1 |
| Hedden, D | 1 |
| MUSSHOFF, K | 1 |
| MUELLER, W | 1 |
| Van Staa, TP | 1 |
| Laan, RF | 1 |
| Barton, IP | 1 |
| Cohen, S | 1 |
| Reid, DM | 2 |
| Cooper, C | 1 |
| Souza, SC | 1 |
| Borges, CT | 1 |
| Jorgetti, V | 1 |
| Pereira, RM | 1 |
| Papierska, L | 1 |
| Rabijewski, M | 1 |
| Sosa, M | 1 |
| Jódar, E | 1 |
| Saavedra, P | 1 |
| Navarro, MC | 1 |
| Gómez de Tejada, MJ | 1 |
| Martín, A | 1 |
| Peña, P | 1 |
| Gómez, J | 1 |
| West, SG | 1 |
| Troutner, JL | 1 |
| Baker, MR | 1 |
| Place, HM | 1 |
| Worth, H | 1 |
| Stammen, D | 1 |
| Keck, E | 1 |
| Shane, E | 3 |
| Rivas, MC | 1 |
| Silverberg, SJ | 3 |
| Kim, TS | 1 |
| Staron, RB | 3 |
| Bilezikian, JP | 1 |
| Rivas, M | 1 |
| Seibel, MJ | 1 |
| Kuiper, J | 1 |
| Mancini, D | 1 |
| Addesso, V | 2 |
| Michler, RE | 1 |
| Factor-Litvak, P | 1 |
| Guaydier-Souquières, G | 1 |
| Kotzki, PO | 1 |
| Sabatier, JP | 1 |
| Basse-Cathalinat, B | 1 |
| Loeb, G | 1 |
| Pichette, V | 1 |
| Bonnardeaux, A | 1 |
| Prudhomme, L | 1 |
| Gagné, M | 1 |
| Cardinal, J | 1 |
| Ouimet, D | 1 |
| Donovan, D | 1 |
| Papadopoulos, A | 1 |
| Jorgesen, B | 1 |
| McGregor, C | 1 |
| Schulman, L | 1 |
| Dujardin, L | 1 |
| Marcelli, C | 1 |
| Hérisson, C | 1 |
| Simon, L | 1 |
| Lems, WF | 1 |
| Jahangier, ZN | 1 |
| Raymakers, JA | 1 |
| Jacobs, JW | 1 |
| Bijlsma, JW | 1 |
| Adachi, JD | 2 |
| Bensen, WG | 2 |
| Brown, J | 1 |
| Hanley, D | 1 |
| Hodsman, A | 2 |
| Josse, R | 2 |
| Kendler, DL | 2 |
| Lentle, B | 2 |
| Olszynski, W | 1 |
| Ste-Marie, LG | 2 |
| Tenenhouse, A | 2 |
| Chines, AA | 2 |
| McEvoy, CE | 1 |
| Ensrud, KE | 1 |
| Bender, E | 1 |
| Genant, HK | 1 |
| Yu, W | 1 |
| Griffith, JM | 1 |
| Niewoehner, DE | 1 |
| Saag, KG | 1 |
| Emkey, R | 1 |
| Schnitzer, TJ | 1 |
| Brown, JP | 2 |
| Hawkins, F | 1 |
| Goemaere, S | 1 |
| Thamsborg, G | 1 |
| Liberman, UA | 1 |
| Delmas, PD | 1 |
| Malice, MP | 1 |
| Czachur, M | 1 |
| Daifotis, AG | 1 |
| McNicholas, WT | 1 |
| Wilkens, BE | 1 |
| Cacoub, P | 1 |
| Chemlal, K | 1 |
| Khalifa, P | 1 |
| Wechsler, B | 1 |
| De Gennes, C | 1 |
| Belmatoug, N | 1 |
| Cohen, P | 1 |
| Ziza, JM | 1 |
| Verdoncq, B | 1 |
| Piette, JC | 1 |
| Adami, S | 1 |
| Devogelaer, JP | 1 |
| Olszynski, WP | 1 |
| Anastassiades, TP | 1 |
| Hanley, DA | 1 |
| Hanly, JG | 1 |
| Jovaisas, A | 1 |
| Ioannidis, G | 1 |
| Stephenson, GF | 1 |
| Barton, I | 1 |
| Pack, S | 1 |
| Chines, A | 1 |
| Dias, R | 1 |
| Shiraki, M | 1 |
| Luengo, M | 1 |
| Picado, C | 1 |
| Del Rio, L | 1 |
| Guañabens, N | 1 |
| Montserrat, JM | 1 |
| Setoain, J | 1 |
| Treadwell, EL | 1 |
| Cunningham, PR | 1 |
| Kowalski, HM | 1 |
| Weaver, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial[NCT01400516] | Phase 4 | 26 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| A Prospective Baseline Assessment of the Risk of Osteoporosis in Patients With Chronic Obstructive Lung Disease and Outcomes After 2 Years; a Pilot Study[NCT01161680] | 30 participants (Actual) | Observational | 2010-07-31 | Completed | |||
| Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol.[NCT00138983] | Phase 3 | 200 participants | Interventional | 2000-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
BMD was measured at the lumbosacral spine antero-posterior and at the femoral neck using a densitometer. A positive change from Baseline (increased bone density) indicates improvement. (NCT01400516)
Timeframe: Baseline and Month 12
| Intervention | grams/centimeters squared (g/cm^2) (Mean) | |||
|---|---|---|---|---|
| Spine, Baseline | Spine, Change from Baseline at Month12 | Femoral neck, Baseline | Femoral neck, Change from Baseline at Month 12 | |
| Control Arm | 0.93 | -0.002 | 0.73 | -0.03 |
| Teriparatide | 0.91 | 0.06 | 0.68 | 0.03 |
The DAS28 score is a measure of the patient's disease activity calculated using the tender joint count (TJC) [28 joints], swollen joint count (SJC) [28 joints], patient's global assessment of disease activity [visual analog scale: 0=no disease activity to 100=maximum disease activity] and C-Reactive Protein (CRP) for a total possible score of 2 to 10. Higher values indicate higher disease activity. A negative change from baseline indicates improvement. (NCT01400516)
Timeframe: Baseline and Month 12
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Baseline | Change from Baseline at Month 12 | |
| Control Arm | 2.73 | -0.50 |
| Teriparatide | 2.66 | 0.42 |
Both hands were scanned using a CT scanner. A semi-automated software tool was used to segment the erosion margins in 3D. A board certified radiologist identified the individual erosions in six sub-regions: radius, ulna, proximal carpals, distal carpals, metacarpophalangeal (MCP) joints and proximal interphalangeal (PIP) joints. The average total in a single hand/wrist was calculated. A negative change from Baseline(less joint erosions) indicates improvement. (NCT01400516)
Timeframe: Baseline and Month 12
| Intervention | cubic millimeter (mm^3) (Median) | |
|---|---|---|
| Baseline | Change from Baseline at Month 12 | |
| Control Arm | 571.4 | 9.1 |
| Teriparatide | 369.8 | -0.4 |
2 reviews available for prednisone and Spinal Fractures
| Article | Year |
|---|---|
[Glucocorticoid-induced osteoporosis].
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Diphosphonates; Female; Fractu | 2007 |
[Risedronate: clinical usage].
Topics: Bone Density; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fractures; Fractures, Stress; H | 2002 |
9 trials available for prednisone and Spinal Fractures
| Article | Year |
|---|---|
Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Cross-Sectional Studies | 2020 |
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bone Densi | 2003 |
Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate.
Topics: Adrenal Cortex Hormones; Asthma; Bone Density; Calcium; Drug Therapy, Combination; Etidronic Acid; F | 1994 |
In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adult; Aged; Bone Density; Bone Diseases, | 1996 |
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium Carbonate; Double-Blind Method; Drug Administr | 1997 |
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Alendronate; Bone Density; Double-Blind Method; Female; Glucoco | 1998 |
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Alendronate; Bone Density; Double-Blind Method; Female; Glucoco | 1998 |
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Alendronate; Bone Density; Double-Blind Method; Female; Glucoco | 1998 |
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Alendronate; Bone Density; Double-Blind Method; Female; Glucoco | 1998 |
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone | 2001 |
Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density; Calcium Channel Blockers; | 2001 |
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Etidronic Acid; Femur Neck; Glucocorticoids; Hip; Huma | 2001 |
25 other studies available for prednisone and Spinal Fractures
| Article | Year |
|---|---|
A 51-Year-Old Man With a Large Posterior Mediastinal Mass.
Topics: Cough; Cytoreduction Surgical Procedures; Decompression, Surgical; Disease Progression; Dyspnea; For | 2021 |
Low disease activity state associated with fewer incident vertebral fractures in Mestizo women with systemic lupus erythematosus.
Topics: Bone Density; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Prednisone; Retrospect | 2023 |
The Early Results of Vertebral Pathological Compression Fracture of Extra- nodal Lymphoma with HIV-positive Patients Treated by Percutaneous Kyphoplasty.
Topics: Adult; Alkynes; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Activ | 2020 |
Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Density; Bone Marrow; Child, Pres | 2019 |
[Acute sensory-motor axonal neuropathy (Guillain-Barre syndrome) following vertebroplasty].
Topics: Accidental Falls; Arthritis, Rheumatoid; Female; Guillain-Barre Syndrome; Humans; Immunocompromised | 2014 |
Percutaneous vertebroplasty in multiple myeloma vertebral involvement.
Topics: Aged; Aged, 80 and over; Back Pain; Bone Cements; Female; Humans; Lumbar Vertebrae; Male; Middle Age | 2008 |
The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus.
Topics: Absorptiometry, Photon; Adolescent; Age Factors; Body Composition; Bone Density; Case-Control Studie | 2008 |
Lichenoid dermatosis induced by alendronate: an unusual skin drug reaction.
Topics: Aged; Alendronate; Biopsy; Bone Density Conservation Agents; Glucocorticoids; Humans; Lichenoid Erup | 2010 |
Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome.
Topics: Bone and Bones; Bone Density; Child; Glucocorticoids; Humans; Lumbar Vertebrae; Male; Nephrotic Synd | 2011 |
Glucocorticoid-related osteoporotic fractures.
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Female; Femoral Fractures; Fractures, Bone; Glucocorti | 2010 |
Multiple vertebral compression fractures in a patient treated with corticosteroids for cystic fibrosis.
Topics: Adolescent; Anti-Inflammatory Agents; Casts, Surgical; Cystic Fibrosis; Fatal Outcome; Fractures, Sp | 2002 |
[VERTEBRAL FRACTURES DURING CORTICOSTEROID THERAPY].
Topics: Adrenal Cortex Hormones; Dexamethasone; Fractures, Bone; Humans; Lumbar Vertebrae; Methyltestosteron | 1964 |
The effect of intravenous zoledronic acid on glucocorticoid-induced multiple vertebral fractures in juvenile systemic lupus erythematosus.
Topics: Adolescent; Azathioprine; Bone Density; Bone Density Conservation Agents; Cervical Vertebrae; Diphos | 2004 |
Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes
Topics: Absorptiometry, Photon; Aged; Bone Density; Cross-Sectional Studies; Female; Glucocorticoids; Humans | 2008 |
Sacral insufficiency fractures in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Causality; Female; Fractures, Stress; Humans; Middle Aged; Osteo | 1994 |
Osteoporosis after cardiac transplantation.
Topics: Absorptiometry, Photon; Bone Density; Cyclosporine; Female; Femur Neck; Heart Transplantation; Human | 1993 |
Fracture after cardiac transplantation: a prospective longitudinal study.
Topics: Bone Density; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; O | 1996 |
Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Cross-Sectional Studies; Female; Follow-Up Studies; G | 1996 |
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Bone Density; Cystic Fibrosis; Female; Fractures, S | 1996 |
[Epidural lipomatosis: complication of long-term corticotherapy. Apropos of 2 cases].
Topics: Adult; Back Pain; Epidural Space; Glucocorticoids; Humans; Lipomatosis; Magnetic Resonance Imaging; | 1996 |
Methods to score vertebral deformities in patients with rheumatoid arthritis.
Topics: Aged; Anthropometry; Arthritis, Rheumatoid; Bone and Bones; Female; Glucocorticoids; Humans; Lumbar | 1997 |
Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Age Factors; Aged; Anti- | 1998 |
What is your diagnosis? Fracture of the body of the axis.
Topics: Animals; Anti-Inflammatory Agents; Axis, Cervical Vertebra; Dog Diseases; Dogs; Fracture Healing; My | 1999 |
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Topics: Adult; Aged; Asthma; Bone Density; Female; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis | 1991 |
Thoracolumbar compression fractures presenting with an acute ileus.
Topics: Aged; Female; Fractures, Spontaneous; Humans; Intestinal Obstruction; Lumbar Vertebrae; Lupus Erythe | 1990 |